Aberer W, Woltsche M, Woltsche-Kahr I, Kränke B
Division of Environmental Dermatology, Department of Dermatology, Auenbruggerplatz 8, A-8036 Graz, Austria.
Eur J Med Res. 2001 Nov 20;6(11):498-504.
Determination of specific IgG antibodies is important for the diagnosis of extrinsic allergic alveolitis (EAA). Various evaluations have however shown, that current methodology lacks sufficient standardization in that the employment of different sources of extracts and techniques makes a comparison of data from one laboratory to another almost impossible.
The aim of this study is to establish an external quality control system and to analyse, what the explanations for the different outcomes from various laboratories might be.
In the past 4 years 5 sera from patients suffering from EAA or healthy controls were sent every 6 months to 11 different allergy laboratories in Austria. The determination of specific IgG antibodies against antigens that are typical for this disease were requested. Results were gained with the method routinely used in the respective laboratory, and then sent back to the reference center for statistical evaluation. Precipitating techniques were used in 8 laboratories during the first mailings, but were gradually exchanged by automated ELISA systems being employed in 8 laboratories in the last mailing.
1127 values were determined in 105 expectedly positive sera and 1003 in 94 negative samples. Of the 562 values obtained with precipitation techniques in positive sera, only 52.0% were reported to be positive, and the results varied considerably among laboratories and antigens. In contrast, 93.3% were positive with commercially available ELISA techniques, with 92.3% for the EnzyDex System and even 95.5% for the UniCAP System. Regarding the specificity however, 93.0% of the expected negative results were correct negative using precipitation methods, whereas merely 75.2% were negative with the EnzyDex System and only 22.5% using the UniCAP System. Moreover 35.8% of the results using this latter method were false-positive.
The traditional precipitation techniques proved not only technically difficult to perform, but also unreliable, difficult to reproduce, insensitive and impractical in daily laboratory work. They suffer from that many draw backs, that their use in daily routine cannot be recommended any more. Automated ELISA systems seem to fulfill the criteria for a routine technique concerning handling, automation, and quality criteria like sensitivity quite well, but not for specificity. Both techniques urgently need external standardization in order to make the results comparable among the different systems and methods; the danger of potentially false-positive results, pretending sensitizations that might be clinically irrelevant in several cases, is high.
特异性IgG抗体的检测对于外源性过敏性肺泡炎(EAA)的诊断至关重要。然而,各种评估表明,目前的方法缺乏足够的标准化,因为使用不同来源的提取物和技术使得不同实验室之间的数据比较几乎不可能。
本研究的目的是建立一个外部质量控制系统,并分析不同实验室结果差异的原因。
在过去4年中,每6个月将5份来自EAA患者或健康对照的血清送往奥地利的11个不同的过敏实验室。要求检测针对该疾病典型抗原的特异性IgG抗体。结果采用各实验室常规使用的方法获得,然后送回参考中心进行统计评估。在第一次邮寄时,8个实验室使用沉淀技术,但在最后一次邮寄时,逐渐被8个实验室采用的自动化ELISA系统所取代。
在105份预期为阳性的血清中测定了1127个值,在94份阴性样本中测定了1003个值。在阳性血清中采用沉淀技术获得的562个值中,只有52.0%被报告为阳性,不同实验室和抗原之间的结果差异很大。相比之下,使用市售ELISA技术的阳性率为93.3%,EnzyDex系统为92.3%,UniCAP系统甚至为95.5%。然而,就特异性而言,使用沉淀法时,93.0%的预期阴性结果为正确阴性,而使用EnzyDex系统时仅75.2%为阴性,使用UniCAP系统时仅22.5%为阴性。此外,使用后一种方法的结果中有35.8%为假阳性。
传统的沉淀技术不仅在技术上难以操作,而且不可靠、难以重复、不敏感且在日常实验室工作中不实用。它们存在许多缺点,以至于不再推荐在日常工作中使用。自动化ELISA系统在操作、自动化以及灵敏度等质量标准方面似乎很好地满足了常规技术的标准,但在特异性方面则不然。这两种技术都迫切需要外部标准化,以使不同系统和方法之间的结果具有可比性;在某些情况下,可能出现假阳性结果,导致临床上可能无关的致敏假象,这种风险很高。